Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Androgen Antagonists × Clear all

Phase

Phase 2 9 Phase 2/3 2 Phase NA 1 Phase 3 1

Status

Completed 11 Recruiting 9 Active not recruiting 7 Unknown 3 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Abiraterone Acetate 1

Interventions

Capecitabine 25 Oxaliplatin 22 Paclitaxel 20 Gemcitabine 17 Fluorouracil 17 Docetaxel 16 Cisplatin 16 Drug Therapy 15 Leucovorin 14 Carboplatin 14 Irinotecan 12 pembrolizumab 11 tislelizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Injections 9 toripalimab 7 Specimen Handling 7 Pemetrexed 7 Trastuzumab 6 Standard of Care 6 Radiotherapy, Intensity-Modulated 6 Radiation 6 Cyclophosphamide 6 Bevacizumab 6 Azacitidine 6 venetoclax 5 sintilimab 5 atezolizumab 5 Temozolomide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡